Business Summary
Halia Therapeutics Inc is a United States-based clinical-stage biopharmaceutical company. The Company is focused on discovering and developing a pipeline of therapeutics to improve patients's lives with chronic inflammatory disorders and neurodegenerative diseases, with its initial programs targeting NEK7 and LRRK2.
Country of Incorporation
United States of America
Incorporation Date
2017-08-30
Business Sector
Pharmaceuticals & Medical Research
Company Address
222 S. Main Street, Suite 500